Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2329-2333

  Nishihira, Kensaku ^a   Shibata, Yoshisato ^a   Ishikawa, Tetsunori ^a   Nomura, Katsumasa ^a   Nakama, Tatsuya ^a   Mine, Daigo ^a   Inoue, Yohei ^a   Ashikaga, Keiichi ^a   Kuriyama, Nehiro ^a   Matsuyama, Akihiko ^a   Imamura, Takuroh ^a   Asada, Yujiro ^b   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cardiovascular diseases; Coronary re intervention; Ischemia; Revascularization

Indexed keywords

RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; REPEAT PROCEDURE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78349265724     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0210     Document Type: Article

References (23)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. New Engl J Med 2003; 349: 1315-1323.
3. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: A randomized trial. JAMA 2004; 292: 2727-2734.
4. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Perez-Vizcayno MJ, Mehilli J, et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: Meta-analysis of randomized trials. J Am Coll Cardiol 2007; 49: 616-623.
5. Liistro F, Fineschi M, Angioli P, Sinicropi G, Falsini G, Gori T, et al. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: The TRUE (Tuscany registry of sirolimus for unselected in-stent restenosis) registry. J Am Coll Cardiol 2006; 48: 270-275.
6. Aminian A, Kabir T, Eeckhout E. Treatment of drug-eluting stent restenosis: An emerging challenge. Catheter Cardiovasc Interv 2009; 74: 108-116.
7. Cosgrave J, Melzi G, Biondi-Zoccai GGL, Airoldi F, Chieffo A, Sangiorgi GM, et al. Drug-eluting stent restenosis: The pattern predicts the outcome. J Am Coll Cardiol 2006; 47: 2399-2404.
8. Chieffo A, Foglieni C, Nodari RL, Briguori G, Sangiorgi G, Latib A, et al. Histopathology of clinical coronary stenosis in drug-eluting versus bare metal stents. Am J Cardiol 2009; 104: 1660-1667.
9. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
10. Kitahara H, Kobayashi Y, Takebayashi H, Fujimoto Y, Nakamura Y, Kuroda N, et al. Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: Retrospective analysis of 4 Japanese hospitals. Circ J 2009; 73: 867-871.
11. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029.
12. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109: 1366-1370.
13. Mori S, Yasuda S, Kataoka Y, Morii I, Kawamura A, Miyazaki S. Significant association of coronary artery calcification in stent delivery route with restenosis after sirolimus-eluting stent implantation. Circ J 2009; 73: 1856-1863.
14. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, et al. Outcome differences with the use of drugeluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009; 103: 491-495.
15. Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GG, Babic R, Airoldi F, et al. Repeated drug-eluting stent implantation for drugeluting stent restenosis: The same or a different stent. Am Heart J 2007; 153: 354-359.
16. Lemos PA, van Mieghem CA, Arampatzis CA, Hoye A, Ong AT, McFadden E, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: Late angiographic and clinical outcomes. Circulation 2004; 109: 2500-2502.
17. Chitani K, Muramatsu T, Tsukahara R, Ito Y, Ishimori H, Hirano K, et al. Predictive factors of re-restenosis after repeated sirolimuseluting stent implantation for SES restenosis and clinical outcomes after percutaneous coronary intervention for SES restenosis. J Interven Cardiol 2009; 22: 354-361.
18. Mishkel GJ, Moore AL, Markwell S, Shelton MC, Shelton ME. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007; 49: 181-184.
19. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088.
20. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270-278.
21. Lim SY, Jeong MH, Hong SJ, Lim DS, Moon JY, Hong YJ, et al. Inflammation and delayed endothelization with overlapping drugeluting stents in a porcine model of in-stent restenosis. Circ J 2008; 72: 463-468.
22. Ino Y, Toyoda Y, Tanaka A, Ishii S, Kusuyama Y, Kubo T, et al. Predictors and prognosis of stent fracture after sirolimus-eluting stent implantation. Circ J 2009; 73: 2036-2941.
23. Kim YH, Lee BK, Park DW, Park KH, Choi BR, Lee CW, et al. Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis. Am J Cardiol 2006; 98: 1451-1454.